[E S] A Greek, Post-marketing, Observational Study of the quAlity of Life in Patients With Psoriasis Treated With Adalimumab - GOAL Study
Phase of Trial: Phase IV
Latest Information Update: 14 Apr 2014
At a glance
- Drugs Adalimumab (Primary)
- Indications Plaque psoriasis
- Focus Therapeutic Use
- Acronyms GOAL
- Sponsors Abbott Laboratories; AbbVie
- 01 Sep 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov record.
- 14 Aug 2012 Planned End Date changed from 1 Jul 2012 to 1 Sep 2012 as reported by ClinicalTrials.gov.
- 08 Feb 2012 Planned end date changed from 1 Apr 2012 to 1 Jul 2012 as reported by ClinicalTrials.gov.